Seguimiento Farmacoterapéutico para pacientes con Diabetes Mellitus que integran el Club de Diabéticos del Instituto Ecuatoriano de Seguridad Social (IESS) Ambato en el período Marzo-Julio 2014

Abstract

A Pharmacotherapeutic Follow-up program was conducted, aimed at the patients that make up the Diabetic Club of the Hospital of the Ecuadorian Social Security Institute "IESS", in the city of Ambato, to detect, classify and reduce the problems related to the medications "PRMs ", Which occurred during his medical treatment. For this investigation, 30 patients were included, of which 27 are female and 3 are male. Their age ranged from 35 to 75 years. The PRMs were classified as Effectiveness, Necessity and Safety according to Scheme established by the 2nd Consensus of Granada. Data obtained during the period (March-September 2014). The program resulted in the detection of a total of 49 PRMs, 17 of Effectiveness, 17 of Necessity and 15 of Safety, obtaining the evolution of 61.23% of them, as well as the identification and reduction of 3 drug interactions, 7 Cases of patients consuming Metformin plus levothyroxine, 1 case of consumption of Metformin plus Furosemide and 2 cases of consumption of insulin and levothyroxine, while the t-Student test, showed that baseline glucose in patients with diabetes mellitus evaluated in the third session, Presented a blood glucose concentration of 134.06 mg / dL, a value that is significantly reduced (P <0.01) when analyzed in the sixth session, in which a concentration of 130.56mg / dl glucose was determined. Through this program of Pharmacotherapeutic Follow-up, the evolution and adequate adherence to the pharmacological treatment of diabetic patients as well as the improvement in their quality of life were achieved. It is recommended that pharmacotherapeutic follow-up programs be implemented at a hospital level for different patient groups as well as chronic pathologies, since excellent results are obtained in the detection and evolution of PRMs characteristic of these diseases.